1. Home
  2. PROF vs SERA Comparison

PROF vs SERA Comparison

Compare PROF & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$7.48

Market Cap

199.3M

Sector

Health Care

ML Signal

HOLD

Logo Sera Prognostics Inc.

SERA

Sera Prognostics Inc.

HOLD

Current Price

$3.48

Market Cap

130.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROF
SERA
Founded
N/A
2008
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
199.3M
130.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PROF
SERA
Price
$7.48
$3.48
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
142.9K
57.1K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,297,000.00
$95,000.00
Revenue This Year
$64.23
$19.22
Revenue Next Year
$113.06
$400.00
P/E Ratio
N/A
N/A
Revenue Growth
67.94
1.06
52 Week Low
$3.76
$1.37
52 Week High
$7.99
$9.13

Technical Indicators

Market Signals
Indicator
PROF
SERA
Relative Strength Index (RSI) 63.62 57.92
Support Level $7.19 $3.20
Resistance Level $7.95 $3.70
Average True Range (ATR) 0.41 0.28
MACD 0.06 0.04
Stochastic Oscillator 81.72 76.93

Price Performance

Historical Comparison
PROF
SERA

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Share on Social Networks: